ResMed Expands Research Development and Innovation facility in UCD

ResMed is to expand its Research Development and Innovation (RDI) facility in University College Dublin (UCD). ResMed research, manufacture and market medical products to combat sleep and respiratory disorders. The expansion is over a 5 year period and will create up to 50 new jobs. The investment is supported by the Irish Government through IDA Ireland. ResMed is based at the NexusUCD Innovation Partnerships Centre at DCU.

ResMed founder Dr Peter Farrell said, “We believe there are great opportunities in growing our presence in Ireland. One of the factors that played a part in our 2011 acquisition of BiancaMed, a UCD spin-out company, was the tremendous advantage of being based in a country that strongly supports research and development.”

Dr Conor Hanley, Managing Director of ResMed Ireland, said, “This investment will allow us to expand our world class team in Ireland and to continue to drive innovation and develop our technology for better monitoring and care of patients with sleep-disordered breathing and other respiratory disorders."

Minister John Perry TD said: Today’s announcement from ResMed, a leading global Medical Technology company, to expand and invest in their Dublin facility, with the creation of additional 50 high-value Research Development and Innovation jobs, is a key example of the Governments Action Plan for Jobs."

Barry O’Leary, Chief Executive of IDA Ireland said: “I am delighted that ResMed has joined Ireland’s strong growing cluster of leading Global and Indigenous Medical Device Companies.”.